The present invention relates to a method for preparing a macromolecular composition comprising phenylglyoxaldehyde-derivatives. The invention also relates to the macromolecular compositions per se, and to methods of using the macromolecular compositions. The macromolecular compositions are useful for undergoing subsequent reactions with small molecules, for instance to remove such small molecules from a solution.

The present invention relates to a method for preparing a macromolecular composition comprising phenylglyoxaldehyde-derivatives. The invention also relates to the macromolecular compositions per se, and to methods of using the macromolecular compositions. The macromolecular compositions are useful for undergoing subsequent reactions with small molecules, for instance to remove such small molecules from a solution.

A novel method for catalytic dehydration of glycerol to acrolein is provided. A fixed bed reactor is used, which is placed in a microwave unit. The feedstock is introduced into the fixed bed reactor after being preheated and gasified. Continuous glycerol dehydration occurs in the presence of a microwave-absorbing catalyst in the fixed bed reactor to form acrolein. The microwave-absorbing catalyst is composed of an active component loaded on a core-shell structure which consists of microwave absorbent coated by an oxide. The uniformity of microwave heating can reduce the formation of hot spot during the reaction and hence improve the catalyst stability. The process and operation is simple, and the unit can steadily run for a long time.

A novel method for catalytic dehydration of glycerol to acrolein is provided. A fixed bed reactor is used, which is placed in a microwave unit. The feedstock is introduced into the fixed bed reactor after being preheated and gasified. Continuous glycerol dehydration occurs in the presence of a microwave-absorbing catalyst in the fixed bed reactor to form acrolein. The microwave-absorbing catalyst is composed of an active component loaded on a core-shell structure which consists of microwave absorbent coated by an oxide. The uniformity of microwave heating can reduce the formation of hot spot during the reaction and hence improve the catalyst stability. The process and operation is simple, and the unit can steadily run for a long time.

The present invention is related to a catalytic process, which includes catalytic compositions for depolymerisation and deoxygenation of lignin contained in the biomass for obtaining aromatic hydrocarbons. The catalytic composition consists of at least one non-noble element from group VIIIB of the periodic table supported on a mesoporous matrix composed of an inorganic oxide, which can be alumina surface-modified with a second inorganic oxide with the object of inhibiting the interaction between the active component and the support. The process of lignin depolymerisation consists of dissolving lignin in a mixture of protic liquids, reacting it I a reaction system by batch or in continuous flow at inert and/or reducing atmosphere, at a temperature of between 60 to 320° C. and a pressure of from 5 to 90 kg/cm.sup.2. When the reaction is developed into a batch system, oxygenated aromatic hydrocarbons are mainly produced, both by thermal as well as catalytic depolymerisation, whereas in a continuous flow reaction system, deoxygenated aromatic hydrocarbons are produced.

The present invention is related to a catalytic process, which includes catalytic compositions for depolymerisation and deoxygenation of lignin contained in the biomass for obtaining aromatic hydrocarbons. The catalytic composition consists of at least one non-noble element from group VIIIB of the periodic table supported on a mesoporous matrix composed of an inorganic oxide, which can be alumina surface-modified with a second inorganic oxide with the object of inhibiting the interaction between the active component and the support. The process of lignin depolymerisation consists of dissolving lignin in a mixture of protic liquids, reacting it I a reaction system by batch or in continuous flow at inert and/or reducing atmosphere, at a temperature of between 60 to 320° C. and a pressure of from 5 to 90 kg/cm.sup.2. When the reaction is developed into a batch system, oxygenated aromatic hydrocarbons are mainly produced, both by thermal as well as catalytic depolymerisation, whereas in a continuous flow reaction system, deoxygenated aromatic hydrocarbons are produced.

The present invention relates to: a catalyst for glycerin dehydration; a preparation method therefor; and an acrolein preparation method using the catalyst. According to one embodiment of the present invention, the catalyst is used in glycerin dehydration so as to exhibit high catalytic activity, a high yield and high acrolein selectivity, and has a characteristic in which carbon is not readily deposited, thereby having a long lifetime compared with that of a conventional catalyst.

The present invention relates to: a catalyst for glycerin dehydration; a preparation method therefor; and an acrolein preparation method using the catalyst. According to one embodiment of the present invention, the catalyst is used in glycerin dehydration so as to exhibit high catalytic activity, a high yield and high acrolein selectivity, and has a characteristic in which carbon is not readily deposited, thereby having a long lifetime compared with that of a conventional catalyst.

The present invention relates to: a catalyst for glycerin dehydration; a preparation method therefor; and an acrolein preparation method using the catalyst. According to one embodiment of the present invention, the catalyst is used in glycerin dehydration so as to exhibit high catalytic activity, a high yield and high acrolein selectivity, and has a characteristic in which carbon is not readily deposited, thereby having a long lifetime compared with that of a conventional catalyst.

Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.